Socioeconomic conditions of one’s community have been attributed to disparities in type 2 diabetes (T2D). Prior research has shown no difference between levels of socioeconomic disadvantage in glycemic outcomes after one year of a carbohydrate-restricted nutrition therapy delivered via continuous remote care (CRNT-CRC). This retrospective analysis explored the likelihood of meeting glycemic targets and changes in cardiometabolic markers over 2 years among people with T2D (n= 10859; 49% female; enrollment mean age 55, BMI 35.7, weight 231.8 lbs, HbA1c 7.7%) utilizing a CRNT-CRC by area deprivation index quintiles. Upon enrollment, patients in more disadvantaged areas had lower odds of meeting glycemic targets than those in the least disadvantaged areas. HbA1c significantly improved at 2 years in all groups, and the disparity was eliminated, where at least 80% in each achieved A1c<8% and at least 60% achieved A1c<7%. Weight, triglycerides, HDL-C, and liver enzymes also significantly improved across groups with no changes in total and LDL-C. This demonstrates that a CRNT-CRC can reduce health disparities of people living with T2D.
B.M. Volk: Employee; Virta Health Corp. Stock/Shareholder; Virta Health Corp. S.J. Athinarayanan: Employee; Virta Health Corp. R.N. Adams: Employee; Virta Health Corp. Stock/Shareholder; Virta Health Corp. C.G.P. Roberts: Other Relationship; Virta Health Corp. A.R. Zoller: Employee; Virta Health Corp. Stock/Shareholder; Virta Health Corp. A.L. McKenzie: Employee; Virta Health Corp. Stock/Shareholder; Virta Health Corp. Employee; Abbott.
